Text Size
4 studies found for:    22070868 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Active, not recruiting PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy
Condition: Metastatic Colorectal Cancer
Interventions: Drug: 5-Fluorouracil, Oxaliplatin, Leucovorin, Panitumumab;   Drug: 5-Fluorouracil, Oxaliplatin, Leucovorin
2 Completed Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment
Conditions: Colon Cancer;   Colorectal Cancer;   Rectal Cancer;   Cancer;   Metastatic Cancer;   Metastatic Colorectal Cancer;   Oncology
Intervention: Drug: panitumumab
3 Unknown † STEPP: A Phase 2, Open-label, Randomized Clinical Trial of Skin Toxicity Treatment in mCRC Subjects Receiving Panitumumab Concomitantly With Second-line Irinotecan Based Chemotherapy
Conditions: Metastatic Colorectal Cancer;   Skin Rash;   Skin Toxicities;   Colon Cancer;   Colorectal Cancer
Intervention: Drug: Panitumumab
4 Completed Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Panitumumab;   Drug: FOLFIRI
To Top

† Indicates status has not been verified in more than two years